Public-registry site landscape for NCT04993755, a Amyotrophic Lateral Sclerosis study sponsored by Transposon Therapeutics, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04993755 (registry record) |
| Sponsor | Transposon Therapeutics, Inc. |
| Condition(s) | Amyotrophic Lateral Sclerosis; Frontotemporal Dementia |
| Phase | PHASE2 |
| Listed sites | 19 |
| Site countries | United States, Belgium, France, Germany, Spain |
Eichor generates a preliminary site-risk snapshot for NCT04993755 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →